Albert Dyrness
Director/Board Member at SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Net worth: 2 015 $ as of 2024-04-29
Profile
Albert D.
Dyrness is the founder and the Managing Director & Vice President of ADVENT Engineering Services, Inc., which was founded in 1988.
He is currently the Vice Chairman-Bioprocess Equipment Standard at the American Society of Mechanical Engineers.
Additionally, he holds the position of Director at Sonnet BioTherapeutics, Inc. since 2019 and Independent Director at Sonnet BioTherapeutics Holdings, Inc. since 2020.
Previously, he served as an Independent Director at Outlook Therapeutics, Inc. from 2015 to 2017.
Mr. Dyrness obtained his undergraduate degree from the Massachusetts Institute of Technology in 1986.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-12-10 | 1,145 ( 0.04% ) | 2 015 $ | 2024-04-29 |
Albert Dyrness active positions
Companies | Position | Start |
---|---|---|
SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Director/Board Member | 2020-03-31 |
American Society of Mechanical Engineers
American Society of Mechanical Engineers Miscellaneous Commercial ServicesCommercial Services American Society of Mechanical Engineers operates non-profit professional organization that enables collaboration, knowledge sharing and skill development for engineering community. The company was founded in 1880 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
ADVENT Engineering Services, Inc.
ADVENT Engineering Services, Inc. Engineering & ConstructionIndustrial Services Advent Engineering Services, Inc. provides consulting services to the national laboratories for the U.S. Department of Energy (DOE). The firm specializes in the design, analysis, and regulatory compliance of structural and mechanical systems critical to the operation of energy producing facilities, and process, systems, and utilities critical to bio-pharmaceutical facilities. The company was founded by Ravi Baliga, Jeff Shulman, Neal Watts, and Albert D. Dyrness in 1988 and is headquartered in San Ramon, CA. | Founder | 1987-12-31 |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Director/Board Member | 2019-09-30 |
Former positions of Albert Dyrness
Companies | Position | End |
---|---|---|
OUTLOOK THERAPEUTICS, INC. | Director/Board Member | 2017-08-31 |
Training of Albert Dyrness
Massachusetts Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
OUTLOOK THERAPEUTICS, INC. | Health Technology |
Private companies | 4 |
---|---|
American Society of Mechanical Engineers
American Society of Mechanical Engineers Miscellaneous Commercial ServicesCommercial Services American Society of Mechanical Engineers operates non-profit professional organization that enables collaboration, knowledge sharing and skill development for engineering community. The company was founded in 1880 and is headquartered in New York, NY. | Commercial Services |
ADVENT Engineering Services, Inc.
ADVENT Engineering Services, Inc. Engineering & ConstructionIndustrial Services Advent Engineering Services, Inc. provides consulting services to the national laboratories for the U.S. Department of Energy (DOE). The firm specializes in the design, analysis, and regulatory compliance of structural and mechanical systems critical to the operation of energy producing facilities, and process, systems, and utilities critical to bio-pharmaceutical facilities. The company was founded by Ravi Baliga, Jeff Shulman, Neal Watts, and Albert D. Dyrness in 1988 and is headquartered in San Ramon, CA. | Industrial Services |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Health Technology |
Sonnet BioTherapeutics Holdings, Inc. |
- Stock Market
- Insiders
- Albert Dyrness